177 related articles for article (PubMed ID: 34016960)
1. Mdivi-1 induces spindle abnormalities and augments taxol cytotoxicity in MDA-MB-231 cells.
Fang CT; Kuo HH; Yuan CJ; Yao JS; Yih LH
Cell Death Discov; 2021 May; 7(1):118. PubMed ID: 34016960
[TBL] [Abstract][Full Text] [Related]
2. A novel strategy for targeted killing of tumor cells: Induction of multipolar acentrosomal mitotic spindles with a quinazolinone derivative mdivi-1.
Wang J; Li J; Santana-Santos L; Shuda M; Sobol RW; Van Houten B; Qian W
Mol Oncol; 2015 Feb; 9(2):488-502. PubMed ID: 25458053
[TBL] [Abstract][Full Text] [Related]
3. Formononetin ameliorates the drug resistance of Taxol resistant triple negative breast cancer by inhibiting autophagy.
Li T; Zhang S; Chen F; Hu J; Yuan S; Li C; Wang X; Zhang W; Tang R
Am J Transl Res; 2021; 13(2):497-514. PubMed ID: 33594306
[TBL] [Abstract][Full Text] [Related]
4. Silibinin-induced mitochondria fission leads to mitophagy, which attenuates silibinin-induced apoptosis in MCF-7 and MDA-MB-231 cells.
Si L; Fu J; Liu W; Hayashi T; Mizuno K; Hattori S; Fujisaki H; Onodera S; Ikejima T
Arch Biochem Biophys; 2020 May; 685():108284. PubMed ID: 32014401
[TBL] [Abstract][Full Text] [Related]
5. Melatonin Protects Against Mdivi-1-Induced Abnormal Spindle Assembly and Mitochondrial Superoxide Production During Porcine Oocyte Maturation.
Yang SG; Joe SY; Bae JW; Heo GD; Park HJ; Koo DB
Front Cell Dev Biol; 2021; 9():693969. PubMed ID: 34307369
[TBL] [Abstract][Full Text] [Related]
6. miR-1207-5p regulates the sensitivity of triple-negative breast cancer cells to Taxol treatment via the suppression of LZTS1 expression.
Hou X; Niu Z; Liu L; Guo Q; Li H; Yang X; Zhang X
Oncol Lett; 2019 Jan; 17(1):990-998. PubMed ID: 30655858
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
8. Mitotic kinesin inhibitors induce mitotic arrest and cell death in Taxol-resistant and -sensitive cancer cells.
Marcus AI; Peters U; Thomas SL; Garrett S; Zelnak A; Kapoor TM; Giannakakou P
J Biol Chem; 2005 Mar; 280(12):11569-77. PubMed ID: 15653676
[TBL] [Abstract][Full Text] [Related]
9. miR-31-5p may enhance the efficacy of chemotherapy with Taxol and cisplatin in TNBC.
Shen X; Lei J; Du L
Exp Ther Med; 2020 Jan; 19(1):375-383. PubMed ID: 31853314
[TBL] [Abstract][Full Text] [Related]
10. Role of inhibitor of yes-associated protein 1 in triple-negative breast cancer with taxol-based chemoresistance.
Li Y; Wang S; Wei X; Zhang S; Song Z; Chen X; Zhang J
Cancer Sci; 2019 Feb; 110(2):561-567. PubMed ID: 30467925
[TBL] [Abstract][Full Text] [Related]
11. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway.
Woods CM; Zhu J; McQueney PA; Bollag D; Lazarides E
Mol Med; 1995 Jul; 1(5):506-26. PubMed ID: 8529117
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity.
Manczak M; Kandimalla R; Yin X; Reddy PH
Hum Mol Genet; 2019 Jan; 28(2):177-199. PubMed ID: 30239719
[TBL] [Abstract][Full Text] [Related]
13. The Putative Drp1 Inhibitor mdivi-1 Is a Reversible Mitochondrial Complex I Inhibitor that Modulates Reactive Oxygen Species.
Bordt EA; Clerc P; Roelofs BA; Saladino AJ; Tretter L; Adam-Vizi V; Cherok E; Khalil A; Yadava N; Ge SX; Francis TC; Kennedy NW; Picton LK; Kumar T; Uppuluri S; Miller AM; Itoh K; Karbowski M; Sesaki H; Hill RB; Polster BM
Dev Cell; 2017 Mar; 40(6):583-594.e6. PubMed ID: 28350990
[TBL] [Abstract][Full Text] [Related]
14. Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol.
Zhou J; O'brate A; Zelnak A; Giannakakou P
Cancer Res; 2004 Dec; 64(23):8708-14. PubMed ID: 15574781
[TBL] [Abstract][Full Text] [Related]
15. Mdivi-1 Alleviates Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats, Possibly via Inhibition of Drp1-Activated Mitochondrial Fission and Oxidative Stress.
Wu P; Li Y; Zhu S; Wang C; Dai J; Zhang G; Zheng B; Xu S; Wang L; Zhang T; Zhou P; Zhang JH; Shi H
Neurochem Res; 2017 May; 42(5):1449-1458. PubMed ID: 28210956
[TBL] [Abstract][Full Text] [Related]
16. Non-anti-mitotic concentrations of taxol reduce breast cancer cell invasiveness.
Tran TA; Gillet L; Roger S; Besson P; White E; Le Guennec JY
Biochem Biophys Res Commun; 2009 Feb; 379(2):304-8. PubMed ID: 19111674
[TBL] [Abstract][Full Text] [Related]
17. To mdivi-1 or not to mdivi-1: Is that the question?
Smith G; Gallo G
Dev Neurobiol; 2017 Nov; 77(11):1260-1268. PubMed ID: 28842943
[TBL] [Abstract][Full Text] [Related]
18. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Associated Macrophages Suppress the Cytotoxic Activity of Antimitotic Agents.
Olson OC; Kim H; Quail DF; Foley EA; Joyce JA
Cell Rep; 2017 Apr; 19(1):101-113. PubMed ID: 28380350
[TBL] [Abstract][Full Text] [Related]
20. Mdivi-1 alleviates blood-brain barrier disruption and cell death in experimental traumatic brain injury by mitigating autophagy dysfunction and mitophagy activation.
Wu Q; Gao C; Wang H; Zhang X; Li Q; Gu Z; Shi X; Cui Y; Wang T; Chen X; Wang X; Luo C; Tao L
Int J Biochem Cell Biol; 2018 Jan; 94():44-55. PubMed ID: 29174311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
